$3.11
+0.04 (+1.30%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+910.0% upside
Low Target
$26.29
Average Target
$31.41
High Target
$48.84
Current Price
$3.11
Current
$3.11
$3.11
Target
$31.41
$31.41
$26.29
$31.41 avg
$48.84
Scenario Analysis
Bear Case
$26.29
745.3%
Low target
Base Case
$31.41
+910.0%
Avg target
Bull Case
$48.84
+1,470.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$5.15
-39.6% from high
52-Week Low
$2.44
+27.5% from low
Target vs 52W High
$31.41
+509.9% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |